Shanghai Labway Clinical Laboratory Co., Ltd.
SZSE:301060.SZ
12.86 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 861.201 | 665.813 | 351.962 | 412.085 | 257.665 | 205.2 | 139.946 | 239.948 | 55.423 | 36.76 | 52.153 |
| Short Term Investments
| 0 | 0 | 420.93 | 120.626 | 227.647 | -46.02 | -41.614 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 861.201 | 665.813 | 772.893 | 532.711 | 485.312 | 205.2 | 139.946 | 239.948 | 55.423 | 36.76 | 52.153 |
| Net Receivables
| 1,033.454 | 2,249.422 | 819.611 | 540.049 | 468.775 | 420.354 | 402.903 | 341.452 | 285.002 | 183.859 | 162.464 |
| Inventory
| 367.71 | 401.518 | 139.444 | 147.128 | 173.68 | 177.901 | 191.555 | 120.493 | 114.468 | 121.544 | 79.825 |
| Other Current Assets
| 74.301 | 87.485 | 27.233 | 170.49 | 21.814 | 51.874 | 298.852 | 52.881 | 34.558 | 96.659 | 162.608 |
| Total Current Assets
| 2,326.523 | 3,388.588 | 1,767.073 | 1,252.907 | 1,171.231 | 1,157.266 | 1,033.257 | 754.774 | 489.45 | 415.886 | 294.586 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 509.735 | 220.959 | 241.107 | 117.373 | 133.078 | 162.694 | 169.322 | 109.38 | 47.786 | 31.461 | 28.814 |
| Goodwill
| 15.242 | 17.638 | 30.086 | 30.086 | 30.086 | 30.086 | 30.086 | 17.822 | 0.184 | 0 | 0 |
| Intangible Assets
| 26.5 | 13.065 | 14.805 | 12.891 | 10.99 | 22.361 | 20.422 | 9.776 | 2.233 | 2.242 | 1.408 |
| Goodwill and Intangible Assets
| 41.742 | 30.702 | 44.891 | 42.977 | 41.077 | 52.447 | 50.508 | 27.598 | 2.417 | 2.242 | 1.408 |
| Long Term Investments
| 14.064 | 16.739 | 32.051 | 36.135 | 40.202 | 58.77 | 54.364 | 0 | 0 | 1.413 | 1.703 |
| Tax Assets
| 48.953 | 30.126 | 13.388 | 14.066 | 9.928 | 9.885 | 7.824 | 0 | 0 | 8.465 | 1.724 |
| Other Non-Current Assets
| 45.843 | 59.759 | 6.974 | 8.056 | 3.501 | 2.154 | 14.757 | 52.192 | 26.094 | 3.804 | 1.096 |
| Total Non-Current Assets
| 660.338 | 358.286 | 338.412 | 218.606 | 227.786 | 285.949 | 296.776 | 189.17 | 76.296 | 47.384 | 34.744 |
| Total Assets
| 2,986.861 | 3,746.874 | 2,105.485 | 1,471.514 | 1,399.017 | 1,443.215 | 1,330.032 | 943.945 | 565.747 | 463.269 | 329.331 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 502.357 | 446.813 | 253.03 | 125.343 | 104.741 | 159.701 | 91.402 | 87.433 | 56.341 | 44.953 | 82.927 |
| Short Term Debt
| 181.863 | 149.429 | 1.999 | 0 | 0 | 30 | 70 | 75.282 | 26.28 | 20 | 25 |
| Tax Payables
| 15.287 | 67.392 | 39.303 | 19.47 | 17.487 | 21.62 | 17.183 | 0 | 0 | 26.171 | 25.044 |
| Deferred Revenue
| 0 | 28.733 | 143.271 | 18.464 | 11.052 | 21.62 | 48.767 | 0 | 0 | 171.466 | 66.062 |
| Other Current Liabilities
| 123.322 | 750.186 | 109.368 | 87.463 | 56.318 | 45.905 | 42.097 | 166.531 | 177.881 | 168.115 | 65.569 |
| Total Current Liabilities
| 822.829 | 1,413.821 | 412.984 | 218.009 | 178.546 | 257.225 | 220.682 | 329.245 | 260.501 | 259.239 | 198.54 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 166.837 | 45.618 | 50.031 | 54.226 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 11.942 | 14.681 | 2.657 | 6.122 | 6.611 | 4.921 | 4.975 | 0 | 0 | 2.9 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -2.657 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 5.088 | 0 | 0 | 6.122 | 0.735 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 183.867 | 60.299 | 52.687 | 6.122 | 7.346 | 4.921 | 4.975 | 0 | 0 | 2.9 | 0 |
| Total Liabilities
| 1,006.696 | 1,474.12 | 465.671 | 224.131 | 185.892 | 262.146 | 225.656 | 329.245 | 260.501 | 262.139 | 198.54 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 400.517 | 400.517 | 400.517 | 352.455 | 352.455 | 352.455 | 352.455 | 98.45 | 89 | 39.729 | 39.729 |
| Retained Earnings
| 750.221 | 1,022.262 | 573.795 | 385.83 | 317.092 | 291.974 | 226.702 | 271.057 | 212.294 | 151.839 | 82.477 |
| Accumulated Other Comprehensive Income/Loss
| -0.653 | 86.526 | 590.624 | 506.12 | 511.183 | 507.502 | 0 | -0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 630.231 | 640.486 | 590.624 | 483.979 | 511.183 | 507.502 | 499.387 | 209.147 | 1.181 | 9.562 | 8.584 |
| Total Shareholders Equity
| 1,780.316 | 2,063.265 | 1,564.936 | 1,222.264 | 1,180.73 | 1,151.93 | 1,078.544 | 578.654 | 302.474 | 201.13 | 130.79 |
| Total Equity
| 1,980.165 | 2,272.755 | 1,639.814 | 1,247.382 | 1,213.125 | 1,181.068 | 1,104.376 | 611.643 | 302.474 | 201.13 | 130.79 |
| Total Liabilities & Shareholders Equity
| 2,986.861 | 3,746.874 | 2,105.485 | 1,471.514 | 1,399.017 | 1,443.215 | 1,330.032 | 940.889 | 562.976 | 463.269 | 329.331 |